Vanda Pharmaceuticals (VNDA) Stock Price, Quote & News

Company Profile

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; Fanapt (iloperidone) for the treatment of bipolar I disorder and Parkinson's disease psychosis, as well as a long acting injectable (LAI) formulation to treat schizophrenia; and Ponvory for the treatment of psoriasis and ulcerative colitis. It...

Industry: Biotechnology

Sector: Healthcare

Phone: 202 734 3400

Fax: 202 296 1450

Website: www.vandapharma.com

Address:

2200 Pennsylvania Avenue NW, Suite 300E, Washington, United States

JazzyJ03 Jun. 16 at 9:59 PM

$VNDA Over $4.90 yo start please.

0 · Reply

Unicorn2020 Jun. 16 at 8:23 PM

$VNDA My account is up $35K after-hours trading. Wtf is going on?

1 · Reply

Texout Jun. 12 at 6:13 PM

$VNDA added 10k

0 · Reply

MarkM Jun. 10 at 4:37 PM

$VNDA Nice set up on the weekly chart. Price has maintained within the trend lines shown (drawn back in March, btw). Recent touch of weekly 50SMA corresponds to upper trend line resistance. A measured move/breakout from this flag from the 12May low of 3.81 gives $7.26. Will be watching for a sustained bullish crossover of the Aroon oscillator as well (shown below volume in attached chart).

1 · Reply

blankstocker Jun. 10 at 1:37 PM

$VNDA First patient dosed announcement.

1 · Reply

HorizonBull Jun. 10 at 12:37 PM

$VNDA 5+ soon

0 · Reply

whitmota Jun. 10 at 3:20 AM

$VNDA I firmly believe $VNDA is undervalued…but have to feel there are higher ROI marketing opportunities than sponsoring the Stanley Cup post game show…

2 · Reply

HFlier Jun. 9 at 7:36 PM

$VNDA 200 Day Moving average kicked our ass today.

0 · Reply

jacckkmm Jun. 9 at 1:40 PM

$VNDA soon?

0 · Reply

onpunch Jun. 9 at 5:32 AM

$VNDA is that a falling wedge?

0 · Reply

Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S

May 27, 2025, 9:00 AM EDT - 20 days ago

Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting

May 16, 2025, 5:30 PM EDT - 4 weeks ago

Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025

May 7, 2025, 7:55 PM EDT - 5 weeks ago

Vanda Pharmaceuticals Inc. (VNDA) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:01 PM EDT - 5 weeks ago

Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results

May 5, 2025, 8:00 AM EDT - 6 weeks ago

Vanda Announces Bysanti™ NDA Filing; FDA Decision Expected in Early 2026

May 2, 2025, 8:46 AM EDT - 6 weeks ago

Vanda Pharmaceuticals to Announce First Quarter 2025 Financial Results on May 7, 2025

Apr 23, 2025, 3:52 PM EDT - 7 weeks ago

FDA Bureaucrats Unlawfully Delay Hearing on Vanda Drug and Falsely Blame Commissioner Makary and the reductions in force at FDA

Apr 7, 2025, 8:00 AM EDT - 2 months ago

Vanda Pharmaceuticals Announces Presentation at 2025 AAN Annual Meeting

Mar 31, 2025, 8:00 AM EDT - 2 months ago

Vanda Pharmaceuticals Announces the Submission of an NDA to the FDA for Bysanti™ for the Treatments of Acute Bipolar I Disorder and Schizophrenia

Feb 24, 2025, 7:00 AM EST - 4 months ago

Vanda Pharmaceuticals announces the publication of an article titled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S"

Feb 13, 2025, 10:29 PM EST - 4 months ago

Vanda Pharmaceuticals, Inc. (VNDA) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 4:01 PM EST - 4 months ago

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 5, 2025, 4:30 PM EST - 4 months ago

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025

Jan 27, 2025, 7:00 AM EST - 5 months ago

Vanda Pharmaceuticals Accepts FDA Opportunity for a Hearing on New Drug Application for Tradipitant in Gastroparesis

Jan 8, 2025, 4:17 PM EST - 5 months ago

Vanda's Letter to FDA Commissioner Highlights Faulty Gastroparesis NDA Review

Dec 20, 2024, 1:26 PM EST - 6 months ago

Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity

Dec 20, 2024, 9:13 AM EST - 6 months ago

Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera

Dec 16, 2024, 9:29 PM EST - 6 months ago

Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.

Nov 12, 2024, 4:58 PM EST - 7 months ago

Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences

Nov 6, 2024, 8:20 PM EST - 7 months ago

Vanda Pharmaceuticals Inc. (VNDA) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:02 PM EST - 7 months ago

Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 1, 2024, 2:05 PM EDT - 8 months ago

Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst

Oct 30, 2024, 4:30 PM EDT - 8 months ago

Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024

Oct 14, 2024, 10:56 AM EDT - 8 months ago

Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd.

Oct 14, 2024, 10:37 AM EDT - 8 months ago

Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals

Oct 14, 2024, 8:19 AM EDT - 8 months ago

Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share

Sep 19, 2024, 3:17 PM EDT - 9 months ago

Vanda Pharmaceuticals decries FDA's rejection of stomach paralysis drug as unjust

Sep 19, 2024, 10:33 AM EDT - 9 months ago

FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies

Sep 19, 2024, 7:57 AM EDT - 9 months ago

U.S. FDA declines to approve Vanda's stomach paralysis drug

Sep 19, 2024, 7:00 AM EDT - 9 months ago

FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis

Sep 11, 2024, 5:00 PM EDT - 9 months ago

Vanda Pharmaceuticals Announces Participation in the 2024 Cantor Global Healthcare Conference

Sep 4, 2024, 5:13 PM EDT - 10 months ago

Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference

Aug 29, 2024, 4:30 PM EDT - 10 months ago

Vanda Pharmaceuticals Announces Participation in the Wells Fargo 2024 Healthcare Conference

Aug 8, 2024, 2:19 PM EDT - 11 months ago

Vanda Pharmaceuticals: I Believe That The Bidding War Is Not Over

Aug 2, 2024, 1:14 PM EDT - 11 months ago

Vanda Pharmaceuticals Inc. (VNDA) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:01 PM EDT - 11 months ago

Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results

Jul 26, 2024, 9:19 AM EDT - 11 months ago

Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024

Jul 1, 2024, 8:01 AM EDT - 1 year ago

Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex

Jun 26, 2024, 6:27 PM EDT - 1 year ago

Future Pak withdraws offer to buy Vanda Pharmaceuticals

JazzyJ03 Jun. 16 at 9:59 PM

$VNDA Over $4.90 yo start please.

0 · Reply

Unicorn2020 Jun. 16 at 8:23 PM

$VNDA My account is up $35K after-hours trading. Wtf is going on?

1 · Reply

Texout Jun. 12 at 6:13 PM

$VNDA added 10k

0 · Reply

MarkM Jun. 10 at 4:37 PM

1 · Reply

blankstocker Jun. 10 at 1:37 PM

$VNDA First patient dosed announcement.

1 · Reply

HorizonBull Jun. 10 at 12:37 PM

$VNDA 5+ soon

0 · Reply

whitmota Jun. 10 at 3:20 AM

$VNDA I firmly believe $VNDA is undervalued…but have to feel there are higher ROI marketing opportunities than sponsoring the Stanley Cup post game show…

2 · Reply

HFlier Jun. 9 at 7:36 PM

$VNDA 200 Day Moving average kicked our ass today.

0 · Reply

jacckkmm Jun. 9 at 1:40 PM

$VNDA soon?

0 · Reply

onpunch Jun. 9 at 5:32 AM

$VNDA is that a falling wedge?

0 · Reply

urallidiots Jun. 6 at 8:06 PM

$VNDA People, I will eat a Ford F150 uncooked if Vanda Pharmaceuticals gets another buyout offer with current management in place. The two suitors who made offers last year have long walked and management has shown that it will respond with the poison pill even if it gets a reasonable offer. I'm bullish, but I'm also prepared to hold for a LONG TIME.

2 · Reply

HFlier Jun. 6 at 6:41 PM

$VNDA Buyout?

0 · Reply

ChristopherRice194 Jun. 6 at 3:12 PM

$VNDA has pharma value but ZBAO has momentum value.

0 · Reply

HorizonBull Jun. 6 at 2:21 PM

$VNDA true bargain

0 · Reply

HorizonBull Jun. 6 at 2:49 AM

$VNDA

0 · Reply

buyitall888 Jun. 4 at 5:49 PM

$VNDA i noticed a lot of ads from this company could it be a buy?

0 · Reply

BioRich Jun. 3 at 3:09 PM

$XBI Add $VNDA to the list. See some very appealing news on the horizon. $PFE $MRK $SNY (Still maintain GUTS, MIST, VERU, CADL and VRNA as my Top 5, but VNDA is well deserving as a 5a.)

0 · Reply

onemillion2012 Jun. 3 at 6:54 AM

$NKTR $ASMB $BCAB $VNDA up we go.. only missing Vanda. Come on. The trend is your friend😆

0 · Reply

HFlier Jun. 2 at 9:06 PM

$VNDA Hey Polymeropoulos do something for the shareholders!

0 · Reply

BioRich Jun. 2 at 1:35 PM

$XBI This week's New Bio picks you many not have heard of: $TLSA (Not Tesla, TSLA, Tiziana Life Sciences) $CANF $LPCN $VNDA MIST, CAPR, GUTS, CADL and NRSN are still huge winners but figured I would try something new. So many great opportunities out there. Follow/Subscribe for more suggestions and perspective. Would love to hear yours, too. That's how we find these gems and learn. Let's make some money. Cheers! ~BioRich Capital

2 · Reply

BioRich Jun. 2 at 5:41 AM

$VNDA Was at the Marlins/Cubs game in Miami a few days back and Vanda Pharmaceuticals had a large advertising presense in the stadium, including a big chunk of the right field wall. Been a fan of the company and now it's exciting to see them getting out there and getting the attention. Been stale for news for a while, but such is with Bios. Follow/Subscribe for more suggestions and perspective. Would love to hear yours, too. That's how we find these gems and learn. Let's make some money. Cheers! ~BioRich Capital

1 · Reply

HorizonBull May. 30 at 12:51 PM

$VNDA sth is cooking. another BO likely

1 · Reply

Market Cap	265.79M
Revenue (ttm)	198.77M
Net Income (ttm)	-18.90M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-9.51%
Debt to Equity Ratio	0.00

Volume	268,400
Avg Vol	542,106
Day's Range	N/A - N/A
Shares Out	58.93M
Stochastic %K	48%
Beta	0.66
Analysts	Strong Sell
Price Target	$12.67